T-Cell Lymphoproliferative Disorders Following Allogeneic Bone Marrow Transplant: A Report of Two Cases and a Literature Review.

allogeneic stem cell transplant allogenic bone marrow transplant post bone marrow transplant complications t-cell large granular lymphocyte leukemia t-cell post-transplantation lymphoproliferative disorders

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
May 2024
Historique:
accepted: 08 05 2024
medline: 10 6 2024
pubmed: 10 6 2024
entrez: 10 6 2024
Statut: epublish

Résumé

Post-transplantation lymphoproliferative disorders (PTLD) are a commonly occurring condition following solid organ transplantation (SOT) and, rarely, hematopoietic stem cell transplantation (HSCT). As the name suggests, a PTLD is a condition where there is a clonal proliferation of lymphoid cells that occurs as a complication after transplantation. Though the clonal origin cell is primarily associated with the B-cell lineage, there are existing cases in the literature describing PTLD from the T-cell lineage. Large granulocytic leukemia (LGL) is one rare T-cell lineage subtype that typically progresses with a passive clinical course and is discovered with leukocytosis and peripheral blood smears demonstrating large granules in lymphocytes. In this study, we describe two patients initially diagnosed with acute myeloid leukemia (AML) who were both found to have T-cell PTLD after undergoing allogeneic hematopoietic stem cell transplant. One was found with a clonal expansion of T-cells on flow cytometry and the other with LGL on peripheral blood and flow cytometry. This discovery was made at 16 and 20 months after their transplant respectively. Distinguishing factors for these two patients are demonstrated by the derivation of lymphoproliferative disorder from graft vs. host disease (GVHD) or viral etiology, which is significant as both of which have been shown to be associated with PTLD. Epstein-Barr virus (EBV) and cytomegalovirus (CMV) positivity have been shown to be associated with PTLD, and both our patients were EBV-negative but had harbored prior CMV infections. Additionally, they had a benign course with no development of cytopenias or symptoms since the time of diagnosis. These two cases add to the growing literature that is working to better characterize the rare development of LGL and, in general, T-cell PTLD following allogeneic bone marrow transplantation.

Identifiants

pubmed: 38854253
doi: 10.7759/cureus.59901
pmc: PMC11160960
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Pagination

e59901

Informations de copyright

Copyright © 2024, Prabhakar et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Auteurs

Nicholas Prabhakar (N)

Internal Medicine, Advocate Lutheran General Hospital, Park Ridge, USA.

Harrah Chiang (H)

Internal Medicine, Advocate Lutheran General Hospital, Park Ridge, USA.

Irma Munoz Verdugo (I)

Internal Medicine, Advocate Christ Medical Center, Oak Lawn, USA.

Ari Hakimian (A)

Hematology and Oncology, Advocate Lutheran General Hospital, Park Ridge, USA.

Shams Bufalino (S)

Hematology and Oncology, Advocate Lutheran General Hospital, Park Ridge, USA.

Jacob Bitran (J)

Hematology and Oncology, Advocate Lutheran General Hospital, Park Ridge, USA.

Classifications MeSH